On average, every 56 seconds in the US,
a nuclear medicine patient is significantly extravasated.
It could be you, a family member, or a friend.
We need your help to fix this patient safety issue.
Take action and support Lucerno’s NRC petition!
Fast. Accurate. Quantitative.
- Scintillation Crystal and Silicon Photomultiplier
- Delivered right to the patient
- Machine learning meets precision medicine
Sometimes a simple idea is the best idea
The Lara® System
- Patient Safety/Quality in Nuclear Medicine Injections
- Immunotherapy assessment*
- Palpable tumor assessment*
- Parkinson’s Disease evaluation*
- Rheumatoid Arthritis quantification*
*These applications have not been cleared or approved by the FDA and are limited by United States law to Investigational Use.
The first commercial application for the Lara® System: Patient Safety
An extravasation, also known as infiltration, is the misadministration of an injection intended for a patient’s vein. Lara provides quality control and quality assurance for nuclear medicine injections. So, patients know when they have been exposed to unintentional radiation and physicians know when images are compromised.
- Published infiltration rate: 15.2%
- Infiltrations reduce diagnostic sensitivity
Annually:
*Company estimates based on 20,000+ monitored injections
As featured in
Contact us
Interested in learning more about The Lara® System?
Contact us for a conversation about monitoring and improving the quality of your nuclear medicine injections and infusions.